Concepedia

Yabing Nan

YN

10

Publications

390

Citations

10

H-Index

2019

Active since

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Dana-Farber Cancer Institute

Harvard University

Zhejiang Cancer Hospital

Qingdao University

Yabing Nan is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in cell signaling, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2019–2025

10

Publications

10

OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation

Qingyu Luo, Xiaowei Wu, Pengfei Zhao et al. · Advanced Science · 2021 · 109 citations · Full text

TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma

Qingyu Luo, Xiaowei Wu, Yabing Nan et al. · Cell Reports · 2020 · 53 citations · Full text

ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness

Qingyu Luo, Xiaowei Wu, Wan Chang et al. · Cell Death and Differentiation · 2019 · 47 citations · Full text

OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis

Wan Chang, Qingyu Luo, Xiaowei Wu et al. · Cell Reports · 2022 · 42 citations · Full text

, , +18

HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity

Yabing Nan, Qingyu Luo, Xiaowei Wu et al. · Molecular Therapy · 2022 · 37 citations · Full text

Rows per page

1–5 of 10